EMEA-000828-PIP05-17
Key facts
Invented name |
Jardiance
|
Active substance |
empagliflozin
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0216/2017
|
PIP number |
EMEA-000828-PIP05-17
|
Pharmaceutical form(s) |
Film-coated tablet
|
Condition(s) / indication(s) |
Prevention of cardiovascular events in patients with chronic heart failure
|
Route(s) of administration |
Oral use
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|